#324 ‒ Metabolism, energy balance, and aging: How diet, calorie restriction, and macronutrients influence longevity and metabolic health | Eric Ravussin, Ph.D.

Episode Summary

Executive Summary: Peter Attia and Eric Ravussin discuss the science and measurement of energy balance, why indirect calorimetry is the gold standard for estimating energy expenditure, and why free-living food intake remains hard to measure. They review Ravussin’s macronutrient-manipulation study, the CALERIE caloric restriction trial, and the promise and limits of CR mimetics, GLP-1 drugs, and AI-enabled nutrition measurement.

Main Topics: Measuring energy expenditure (Priority: 5/5): Ravussin explains direct vs indirect calorimetry, metabolic chambers, validation methods, and why chamber-based measurement is highly precise but constrained to controlled settings. Energy balance and appetite regulation (Priority: 5/5): The conversation explores why body weight is so tightly regulated despite noisy intake/output, with emphasis on leptin, fat-free mass, resting metabolic rate, and the dominant role of appetite/energy intake. Macronutrient composition and energy expenditure (Priority: 4/5): They revisit the isocaloric ketogenic vs higher-carbohydrate study testing whether changing fat/carbohydrate ratios alters energy expenditure; the effect was modest and transient. Exercise, appetite, and weight control (Priority: 4/5): They distinguish exercise as essential for health but limited for weight loss, while acknowledging it may help weight-loss maintenance and influence appetite timing and food choice. CALERIE and caloric restriction (Priority: 5/5): Ravussin details the long-term caloric restriction trial, its recruitment, adherence strategies, biomarker improvements, and evidence for metabolic adaptation and reduced oxidative stress. CR mimetics, GLP-1s, and aging biology (Priority: 4/5): The discussion turns to whether drugs like GLP-1 agonists, metformin, acarbose, SGLT2 inhibitors, and rapamycin can reproduce caloric restriction benefits, with skepticism about some candidates and enthusiasm for testing others. Precision nutrition, epidemiology, and AI (Priority: 4/5): They argue that food-frequency questionnaires are too weak for causal policy, and that future nutrition science will require better real-world measurement tools, likely powered by AI and sensor-based tracking.

Key Arguments: Indirect calorimetry and metabolic chambers provide highly accurate estimates of energy expenditure and substrate oxidation, but free-living energy intake remains much harder to measure reliably. Body weight is regulated surprisingly well over time, but the dominant driver of population weight gain is the food environment; individual differences likely reflect both genetics and environment. Most of the regulation of body weight appears to occur on the intake side rather than the expenditure side; Ravussin estimated roughly 80% of the effect is attributable to energy intake. Exercise is crucial for health and for maintaining weight loss, but it is generally a weak standalone tool for weight loss because of compensation through appetite and/or reduced non-exercise activity. The macronutrient study suggested that a ketogenic, low-carbohydrate diet can transiently raise 24-hour and sleeping energy expenditure by a bit over 100 kcal/day, but the effect faded by weeks 3-4. CALERIE showed that sustained caloric restriction in carefully selected, highly supported participants improved many biomarkers of secondary aging and some markers related to primary aging, including oxidative stress and mitochondrial turnover. Caloric restriction likely improves health through multiple mechanisms, including lower oxidative stress, improved insulin sensitivity, and enhanced mitochondrial biogenesis/turnover. Not all proposed CR mimetics are equally credible; Ravussin is skeptical of sirtuins and more open to testing GLP-1 agonists and other drugs with stronger evidence bases. Nutritional epidemiology should generate hypotheses, not be the sole basis for policy; better causal studies and better measurement technologies are needed. AI and sensor-based tools may eventually make free-living dietary assessment accurate enough to support precision nutrition and individualized experimentation.

Data Points: NIH budget: $33–35 billion - Ravussin described the scale of NIH funding and the intramural/extramural distinction. NIH extramural share: 80%–85% - He noted most NIH money goes to academic institutions rather than intramural labs. Pennington staff: ~500 people - He described Pennington Biomedical as a large research-only institution focused on nutrition and obesity. Pennington functional budget: ~$80 million/year - Annual operating scale of the institute. Indirect calorimetry precision: ~2.5% - Accuracy/precision of metabolic chamber measurements after validation. Chamber validation deviation: ~3% - Acceptable deviation when validating chambers against known combustion sources. Population weight gain in U.S.: ~10 kg (22 lb) from the 1980s to 2010 - Used to illustrate the impact of the food environment on obesity prevalence. Macronutrient study effect size: >100 kcal/day increase - Transient increase in sleeping metabolic rate and 24-hour energy expenditure on ketogenic diet. Macronutrient study duration: 4 weeks - Isocaloric ketogenic vs higher-carbohydrate intervention period. Macronutrient study sample: ~16 subjects - Small crossover study with each participant serving as their own control. CALERIE grant size: $10.4 million original; +$1.5 million supplement - Total cost discussed for the Pennington portion of the trial. CALERIE recruitment: >5,000 screened to enroll 225 - Illustrates the intensity of screening and selection for adherence. CALERIE retention: 95% ad libitum; 85% caloric restriction - Two-year follow-up retention across groups. CALERIE weight loss: 12% at 1 year; 10.4% at 2 years - Average weight loss in the caloric restriction group. CALERIE achieved restriction: ~12.5% overall by 2 years - Participants achieved about half of the intended 25% restriction. CALERIE energy requirement: ~2,400 kcal/day - Average estimated energy requirement used to set restriction targets. CALERIE lean mass loss: <25% of total weight loss - Lean mass was preserved relatively well during weight loss. Biosphere 2 weight loss: ~15% - Residents lost weight during unintended caloric restriction in Biosphere 2. Biosphere 2 energy expenditure deficit: ~200 kcal/day below expected - Measured after adjusting for body composition. Time-restricted eating study: 6-hour window in prior human study; future study likely ~8 hours - Discussed as a planned comparison versus caloric restriction.

Pivotal Quotes: "“I think that there are signals coming from when FGF21, which is a signal coming from the liver, was discovered. I said, ah, maybe that is it. Or when you have some of the myokines coming from the skeletal muscle, I said, maybe this is it. And it's not been it.”" — Eric Ravussin: On the still-unsolved biology of body-weight regulation and appetite control. "“I would say 80% is on the side of the energy intake.”" — Eric Ravussin: His estimate of where most body-weight regulation occurs when comparing intake vs expenditure. "“We have no tools to measure energy intake. But it's going to come.”" — Eric Ravussin: On the future of nutrition measurement and the need for better real-world tools.

Implications: The episode argues that obesity science needs better causal experiments and better measurement, not just epidemiology. For listeners, the practical takeaway is that health and weight are not the same problem: exercise matters greatly for health, while durable weight control usually requires some form of intake restriction, ideally personalized.